Boston Scientific (NYSE:BSX – Free Report) had its target price hoisted by Citigroup from $71.00 to $79.00 in a research note published on Wednesday morning, Benzinga reports. They currently have a buy rating on the medical equipment provider’s stock. Several other equities research analysts also recently weighed in on BSX. Raymond James upped their price […]
Boston Scientific (NYSE:BSX – Free Report) had its target price upped by Argus from $69.00 to $80.00 in a research note issued to investors on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the medical equipment provider’s stock. Other equities research analysts have also issued research reports about the company. Citigroup […]
Trust Point Inc. acquired a new stake in Boston Scientific Co. (NYSE:BSX – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 18,420 shares of the medical equipment provider’s stock, valued at approximately $1,065,000. A number of other […]
Boston Scientific (NYSE:BSX – Get Free Report) had its price objective boosted by analysts at Argus from $69.00 to $80.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. Argus’ price target points to a potential upside of […]
CPA Asset Management LLC decreased its stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 18.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,968 shares of the medical equipment provider’s stock after selling 1,092 shares during the period. CPA […]